Literature DB >> 6567611

Enterobacter sepsis in infants and children due to contaminated intravenous fluids.

N S Matsaniotis, V P Syriopoulou, M C Theodoridou, K G Tzanetou, G I Mostrou.   

Abstract

Sixty-three cases of nosocomial sepsis occurring from April through October 1981, in a 500-bed pediatric hospital, were traced to bacterial contamination of intravenous fluid produced by a single manufacturer. Two species of uncommon blood stream pathogens, Enterobacter cloacae and Enterobacter agglomerans contaminated the fluid. Infections with these organisms might have contributed to the death of four patients; two who were immunosuppressed, one who was asplenic and one premature infant. Epidemiologic and laboratory investigations identified the site of contamination to be within the screw-caps of the bottles containing the intravenous fluid. Contamination occurred during insertion of the intravenous fluid administration set into the bottle. The "epidemic" terminated when the hospital discontinued the use of infusion fluids from that manufacturer. We conclude that intravenous fluids should be examined during outbreaks of nosocomial bacteremia due to unusual pathogens.

Entities:  

Mesh:

Year:  1984        PMID: 6567611     DOI: 10.1017/s0195941700060872

Source DB:  PubMed          Journal:  Infect Control        ISSN: 0195-9417


  19 in total

1.  Use of quantitative microbiological analyses to trace origin of contamination of parenteral nutrition solutions.

Authors:  Sucharit Bhakdi; Irene Krämer; Ekkehard Siegel; Bernd Jansen; Martin Exner
Journal:  Med Microbiol Immunol       Date:  2012-04-07       Impact factor: 3.402

Review 2.  Enterobacter spp.: pathogens poised to flourish at the turn of the century.

Authors:  W E Sanders; C C Sanders
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

Review 3.  Pathogenesis of infections related to intravascular catheterization.

Authors:  D A Goldmann; G B Pier
Journal:  Clin Microbiol Rev       Date:  1993-04       Impact factor: 26.132

4.  Structure of the D-alanylgriseoluteic acid biosynthetic protein EhpF, an atypical member of the ANL superfamily of adenylating enzymes.

Authors:  Asim K Bera; Vesna Atanasova; Swarna Gamage; Howard Robinson; James F Parsons
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-05-15

5.  Achromobacter spp. bacteremia outbreak related to contaminated furosemide ampoules.

Authors:  Rajalakshmi Arjun; Kalpana E John; Vettakkara Kandy Muhammed Niyas; Sreerekha R Nair; Viji Mohan; Raveendran Sarala Ratheesh
Journal:  Infez Med       Date:  2021-09-10

6.  Phylogeny and identification of Pantoea species and typing of Pantoea agglomerans strains by multilocus gene sequencing.

Authors:  Alexis Delétoile; Dominique Decré; Stéphanie Courant; Virginie Passet; Jennifer Audo; Patrick Grimont; Guillaume Arlet; Sylvain Brisse
Journal:  J Clin Microbiol       Date:  2008-12-03       Impact factor: 5.948

7.  Should we use closed or open infusion containers for prevention of bloodstream infections?

Authors:  Manuel S Rangel-Frausto; Francisco Higuera-Ramirez; Jose Martinez-Soto; Victor D Rosenthal
Journal:  Ann Clin Microbiol Antimicrob       Date:  2010-02-02       Impact factor: 3.944

8.  Outbreak of Burkholderia cepacia bacteremia in a pediatric hospital due to contamination of lipid emulsion stoppers.

Authors:  C Doit; C Loukil; A-M Simon; A Ferroni; J-E Fontan; S Bonacorsi; P Bidet; V Jarlier; Y Aujard; F Beaufils; E Bingen
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

9.  Diversity of aminoglycoside resistance in Enterobacter cloacae in Greece.

Authors:  A C Vatopoulos; A Tsakris; L S Tzouvelekis; N J Legakis; T L Pitt; G H Miller; K J Shaw; M Antreou; M Nikolopoulou; Z Komninou
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-02       Impact factor: 3.267

10.  Pantoea agglomerans, a plant pathogen causing human disease.

Authors:  Andrea T Cruz; Andreea C Cazacu; Coburn H Allen
Journal:  J Clin Microbiol       Date:  2007-04-18       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.